布地奈德联合孟鲁司特钠治疗小儿喘息性支气管炎的临床价值

Clinical Value of Budesonide Combined with Montelukast Sodium in the Treatment of Asthmatic Bronchitis in Children

目的:观察布地奈德联合孟鲁司特钠治疗小儿喘息性支气管炎的临床价值。方法:以某院2018年2月~2018年10月收治的50例小儿喘息性支气管炎患儿为研究对象,根据入院时间分为研究组与对照组各25例。对照组行布地奈德治疗,研究组在对照组治疗方法下实施孟鲁司特钠治疗方法,比较两组患者临床效果、肺功能,并比较两组患儿治疗满意度。结果:研究组患者临床效果高于对照组,肺功能高于对照组,存在统计学意义(P<0.05);研究组患儿治疗满意度高于对照组(P<0.05)。结论:两种药物联合治疗小儿喘息性支气管炎效果良好,有助于改善肺功能。

Objective:To observe the clinical value of budesonide combined with montelukast sodium in the treatment of asthmatic bronchitis in children.Methods:50 cases of pediatric asthmatic bronchitis admitted to a hospital from February 2018 to October 2018 were divided into study group and control group according to the admission time.The control group was treated with budesonide.The study group was treated with montelukast sodium based on the control group.The clinical effects,lung function,and the treatment satisfaction of the two groups were compared.Results:The clinical effect of the study group was higher than that of the control group;the lung function was higher than the control group,and there was statistical significance(P<0.05).The treatment satisfaction of the study group was higher than that of the control group(P<0.05).Conclusion:The combination of the two drugs is effective in the treatment of children with asthmatic bronchitis and helps to improve lung function.